Why the study?
Peripheral arterial disease has increased with rising numbers of patients with kidney disease or diabetes, prompting assessment of its prevalence in hemodialysis patients with diabetes.
Does the cardio-ankle vascular index (CAVI) predict the presence of peripheral arterial disease in patients undergoing chronic hemodialysis?
Does the cardio-ankle vascular index (CAVI) predict the presence of peripheral arterial disease in patients undergoing chronic hemodialysis?
The cardio-ankle vascular index (CAVI) may be a useful screening tool for predicting macrovascular complications like peripheral arterial disease in diabetic patients on hemodialysis.
May support CAVI for PAD screening in hemodialysis; leaves open prospective predictive value.
BACKGROUND: Peripheral arterial disease (PAD) has increased in association with the increase in the numbers of patients with kidney disease or diabetes. The aim of this study was to assess the prevalence of PAD in hemodialysis patients with diabetes. METHODS: To examine the usefulness of the cardio-ankle vascular index (CAVI) to screen for the presence of PAD, cross-sectional studies of 100 patients undergoing chronic hemodialysis were performed. The CAVI and other inflammatory markers were evaluated. RESULTS: The CAVI was markedly elevated in patients with a history of PAD or cardiovascular disease. When dialysis patients were classified on the basis of CAVI quartiles, increased CAVI was associated with other risk factors for PAD. CONCLUSION: The prevalence of PAD is high in elderly diabetic patients on hemodialysis. The present findings suggest that the CAVI can be a useful index that predicts the occurrence of macrovascular complications in dialysis patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Furuya et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: